scispace - formally typeset
I

Isabelle Migeotte

Researcher at Université libre de Bruxelles

Publications -  71
Citations -  4906

Isabelle Migeotte is an academic researcher from Université libre de Bruxelles. The author has contributed to research in topics: Ligand (biochemistry) & Gastrulation. The author has an hindex of 21, co-authored 62 publications receiving 3430 citations. Previous affiliations of Isabelle Migeotte include Kettering University & Ludwig Maximilian University of Munich.

Papers
More filters
Journal ArticleDOI

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang, +172 more
- 23 Oct 2020 - 
TL;DR: The COVID Human Genetic Effort established to test the general hypothesis that life-threatening COVID-19 in some or most patients may be caused by monogenic inborn errors of immunity to SARS-CoV-2 with incomplete or complete penetrance finds an enrichment in variants predicted to be loss-of-function (pLOF), with a minor allele frequency <0.001.
Journal ArticleDOI

Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses.

TL;DR: The physiological role of the FPR family is still incompletely understood, due in part to the large variety of ligands, the redundancy with other chemoattractant agents, and the lack of clear orthologs between human and mouse receptors.
Journal ArticleDOI

CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist.

TL;DR: MCP-3 could be considered as a natural antagonist for CCR5, probably as a consequence of its inability to downregulate the receptor, and five other CC-chemokines could compete for [(125)I]-MIP-1beta binding, although with variable potencies.
Journal ArticleDOI

Human genetic and immunological determinants of critical COVID-19 pneumonia

Qian Zhang, +160 more
- 28 Jan 2022 - 
TL;DR: In this article , the molecular and cellular determinants of critical COVID-19 pneumonia were reviewed and the TLR3- and TLR7-dependent production of type I interferons by respiratory epithelial cells and plasmacytoid dendritic cells, respectively, is essential for host defence against SARS-CoV-2 infection.